BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Endocrine/metabolic Chinese scientists divulge new XOR inhibitors Dec. 3, 2025 Apichope Bio Pharmaceutical Co. Ltd., Apichope Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have synthesized xanthine dehydrogenase/oxidase (XDH; XOR) inhibitors reported to be useful for the treatment of hyperuricemia, gout, arthritis and heart failure. BioWorld ScienceEndocrine/metabolicPatents